| Source Date | Board Meeting Date | Details |
|
02-Mar-2026
|
07-Mar-2026
|
Quarterly Results
|
|
20-Feb-2026
|
27-Feb-2026
|
Inter alia, to consider and approve the following matters: 1. To consider and take note of the resignation tendered by one of the Executive Directors Mr. Dayanand Ray. 2. Proposed Reversal of Acquisition of Sunbridge Agro Private Limited (SAPL):- The Company had, in September 2025, entered into Share Purchase Agreements (SPAs) for acquisition of equity shares of SAPL as part of its strategic objective to acquire controlling stake. The said acquisition was proposed to be partial funded through proceeds from a Qualified Institutional Placement (QIP). However, due to the Company?s inability to successfully complete the QIP and consequently non-receipt of the proposed proceeds, the Company has not been able to fulfil payment obligations under the SPAs within the stipulated timelines. In view of the above, the Board will consider and evaluate a proposal for reversal/settlement of the said acquisition transaction, subject to mutual discussions with the concerned parties and applicable statutory and regulatory compliances.
|
|
31-Oct-2025
|
05-Nov-2025
|
Quarterly Results & Interim Dividend
|
|
04-Aug-2025
|
12-Aug-2025
|
Quarterly Results
|
|
18-Jul-2025
|
25-Jul-2025
|
Inter alia, to consider and approve:- 1. The acquisition of an overseas business entity in accordance with the provisions of the Companies Act, 2013 and other applicable laws, rules and regulations, as amended, subject to such regulatory/ statutory approvals as may be required. 2. Issue of Equity Shares on Preferential basis in accordance with provisions of Chapter V of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and other applicable rules, regulations and guidelines of SEBI and applicable provisions of Companies Act, 2013. 3. Shifting of Registered office of the Company from National Capital Territory of Delhi to the State of Maharashtra.
|
|
04-Jul-2025
|
09-Jul-2025
|
Inter alia, to consider and approve the following business matters: 1. The acquisition of an Overseas business entity in accordance with the provisions of the Companies Act, 2013 and other applicable laws, rules and regulations, as amended, subject to such regulatory/ statutory approvals as may be required. 2. Raising of funds by issue of Equity Shares through Qualified Institutions Placement (?QIP?) for an aggregate amount up to Rs.300,00,00,000/- (Rupees Three Hundred Crores Only) or an equivalent amount thereof (inclusive of such premium or discount as may be fixed on such Equity Shares) subject to the receipt of approval of the Members of the Company and such other approval(s)/ permission(s)/ consent(s)/ sanction(s) of any government/ regulatory/ statutory authorities, as may be required. 3. Issue of Equity Shares on Preferential basis in accordance with provisions of Chapter V of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and other applicable rules, regulations and guidelines of SEBI and applicable provisions of Companies Act, 2013. 4. Any other item with the permission of the Chair
|
|
25-Jun-2025
|
01-Jul-2025
|
Inter alia, to consider and approve the following business matters: 1. To discuss and evaluate the proposal for raising funds up to an amount of Rs. 75 Crores (Rupees Seventy Five Crores Only) by way of preferential allotment, issue of convertible warrants, Foreign Currency Convertible Bonds (FCCBs), Qualified Institutional Placement (QIP) or any other permissible instruments/modes, subject to necessary approvals from Shareholders, regulatory bodies and other stakeholders. 2. Any other item with the permission of the Chair.
|
|
14-May-2025
|
27-May-2025
|
Audited Results
|
|
22-Jan-2025
|
30-Jan-2025
|
Quarterly Results
|
|
09-Jan-2025
|
16-Jan-2025
|
Stock Split(Cancelled) & Rights Issue(Cancelled)
|